CENTRAL NERVOUS SYSTEM (CNS)
At Sterling Analytics, we bring deep expertise in statistical analysis and data strategy to support clinical trials in neuroscience and mental health. These therapeutic areas demand tailored methodologies, sensitive outcome measures, and innovative trial designs to address the complexities of diagnosis, treatment response, and patient variability.
From protocol development to regulatory submission, Sterling Analytics transforms complex data into actionable insights—empowering sponsors to advance treatments that improve lives in some of the most challenging areas of healthcare.
Our Areas of Expertise:
🟣 Sleep disorders-
We support trials evaluating pharmacologic and behavioral therapies for insomnia, hypersomnia, and circadian rhythm disorders. Our analytics ensure accurate endpoint definition, including sleep architecture metrics, patient-reported outcomes, and wearable device data.
🟣Major depressive disorders & Mood/Psychotic disorders-
From early-phase efficacy studies to long-term safety monitoring, we offer statistical guidance for trials involving antidepressants, mood stabilizers, and antipsychotic therapies. Our work includes response trajectory modeling, subgroup analysis, and integration of PROs and clinician-rated scales.
🟣Traumatic brain injuries-
Clinical research in TBI requires careful consideration of heterogeneity in injury severity and recovery patterns. Sterling Analytics delivers adaptive trial support, longitudinal data modeling, and neurocognitive outcome analysis to advance therapies for both acute and chronic TBI.
🟣 Dementia (Alzheimer’s disease and Parkinson’s disease)-
We provide end-to-end analytics for studies focused on disease modification, cognitive function, behavioral symptoms, and caregiver burden. Our team is experienced in handling multi-modal data from imaging, biomarkers, and cognitive assessments, ensuring high-quality, submission-ready outputs.